The Akt proto-oncogene links Ras to Pak and cell survival signals

Y Tang1, H Zhou, A Chen

  • 1Department of Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA.

Insights

The Ras oncogene

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • Ras oncogene controls cell growth, survival, and differentiation.
  • The pathway from Ras to Pak protein kinase (p65(pak)) is not fully understood.
  • Phosphoinositide 3 (PI3) kinase is a known Ras effector, linking to Rac and Akt.

Purpose of the Study:

  • To elucidate the signaling pathway from Ras to Pak.
  • To investigate the role of Akt in Ras-mediated Pak activation.
  • To define a novel oncogene-mediated cell survival pathway.

Main Methods:

  • Transfection assays using dominant-negative mutants.
  • Development of a novel cell-free system for studying Ras-Pak signaling.
  • Immunodepletion assays to assess protein contributions.

Main Results:

  • Activated Akt stimulates Pak activity.
  • Ras activation of Pak is dependent on Akt and independent of Rac/Cdc42.
  • A cell-free system confirmed Akt's essential role in Ras-Pak signaling.
  • Pak activation by Ras/Akt signaling reduces apoptosis by phosphorylating Bad.

Conclusions:

  • Akt acts as a crucial mediator in the Ras-Pak signaling pathway.
  • This study defines a new oncogene-driven survival signal involving Akt and Pak.
  • Targeting this pathway may offer therapeutic strategies for cancer.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...